Abstract
To examine a possible synergistic role for p73 and cisplatin (cis-diamminedichloroplatinum II) in HeLa cells with a nonfunctional p53 protein, we established stable HeLa/p73 clones using a tetracycline inducible eukaryotic expression vector. The HeLa/p73 clones were not characterized by changes in growth or morphology. Cell death analysis, however, indicated a greater sensitivity to cisplatin in the p73-overexpressed HeLa cells than determined for the non-induced HeLa cells. This increased sensitivity seems to affect an induction of a sub-G1 population as assessed from flow cytometry analysis. The increased sub-G1 population may, in turn, result from a reduction of cyclin D1 and B1 expression by cisplatin in the presence of p73. Hoechest staining indicated an increased number of dead cells in the p73-induced cells compared to the non-induced cells. Poly ADP-ribose polymerase (PARP) cleavage was shown to be distinct in the p73-overexpressed cells compared to non-induced cells, which suggests that p73 modulates the cisplatin-induced apoptosis. Therefore, a synergistic effect of p73 and cisplatin to induce apoptosis could lead to new treatment for some types of human cancers.
References
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T D KessisK R Cho
Jan 1, 1997·Cytometry·A VaismanS G Chaney
Aug 22, 1997·Cell·M KaghadD Caput
Sep 20, 1997·Nature·C A JostW G Kaelin
Aug 12, 1998·Gynecologic Oncology·A HusainD R Spriggs
Jan 16, 1999·The Journal of Biological Chemistry·Z M YuanD Kufe
Jun 11, 1999·Oncogene·L FangS A Aaronson
Jul 3, 1999·Nature·J G GongJ Y Wang
Jul 3, 1999·Nature·R AgamiY Shaul
Jul 3, 1999·Nature·Z M YuanD Kufe
Aug 3, 1999·The Journal of Clinical Investigation·F BunzB Vogelstein
Dec 10, 1999·Experimental Cell Research·K H KangK H Choi
Jan 19, 2000·Cell Death and Differentiation·M LevreroJ Y Wang
Feb 9, 2000·Japanese Journal of Cancer Research : Gann·Y MinagawaN Terakawa
May 16, 2000·Cancer Gene Therapy·M CascallóA Mazo
May 23, 2001·Leukemia·N RadosevicF Ajchenbaum-Cymbalista
Aug 8, 2001·The Journal of Biological Chemistry·L DubrezM C Favrot
Aug 23, 2001·Mutation Research·T R DunkernB Kaina
Oct 12, 2001·Cancer Letters·L F Qin, I O Ng
Oct 13, 2001·Biochemical Pharmacology·R H LeeJ S Jung
Dec 26, 2001·Oncogene·K C KimK H Choi
Jul 4, 2002·FEBS Letters·Kyung-Hwa KangKyung Hee Choi
Jan 22, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lian DuanKiyotaka Yamamoto
Oct 27, 2004·Cancer·Ryungsa KimTetsuya Toge
Sep 1, 2005·The Journal of Biological Chemistry·Qize Wei
Citations
Mar 2, 2011·Molecules and Cells·Jin-Ah ParkKeun-Cheol Kim
Sep 16, 2008·Molecular Cancer Therapeutics·Yingyu MaCandace S Johnson
Jul 20, 2007·Blood·Arnon P KaterThomas J Kipps
Jan 27, 2010·Toxicology·Wei LiangRobert Chunhua Zhao
Jul 21, 2007·Biochemical and Biophysical Research Communications·T M HansenG Melino
Oct 13, 2007·Molecular Carcinogenesis·M Fernanda LaraJesús M Paramio
May 6, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Allison WalterValérie B Schini-Kerth
Jan 2, 2009·Cancer Research·Bin ZhangJun Jian Huang
Oct 3, 2021·British Journal of Cancer·Teruyuki KobayashiYuichiro Doki